Abstract
Two kinetically different pathways that generate prostaglandin (PG) from endogenous arachidonic acid, the immediate and delayed phases, imply the recruitment of different sets of biosynthetic enzymes, the expression and activation of which are tightly regulated by distinct transmembrane signalings. The immediate phase of PG biosynthesis occurs within several minutes of stimulation, is elicited by agonists that mobilize intracellular Ca2+ and is characterized by a burst release of arachidonic acid (AA) initiated by Ca2+-dependent phospholipase A2 (PLA2) which is subsequently converted to bioactive PGs by the sequential actions of cyclooxygenase (COX) and terminal PG synthases. The delayed phase of PG biosynthesis is accompanied by the continuous supply of AA and its conversion to PGs, often PGE2, over long culture periods following growth or pro-inflammatory stimuli. Here we report the molecular identification of the PLA2 and COX isozymes involved in the PG biosynthetic pathway in rat fibroblasts and hepatocytes and provide evidence that type HA secretory PLA2 (sPLA2-IIA) plays an augmentative role in prolonged PG production following proinflammatory stimuli.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Refferences
H. Kuwata, Y. Nakatani, M. Murakami, and I. Kudo. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem.273: 1733 (1998)
J.A. Tischfield. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem.272: 17247 (1997)
H. Suga, H., M. Murakami, I. Kudo, and K. Inoue. Participation in cellular prostaglandin synthesis of type II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan. Eur. J. Biochem.218: 807 (1993)
M. Murakami, I. Kudo, and K. Inoue. Molecular nature of phospholipase A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells: possible participation of cytosolic and extracellular type II phospholipases A2. J. Biol. Chem.268: 839 (1993)
M. Murakami, Y. Nakatani, and I. Kudo. Type II secretory phsopholipase A2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J. Biol. Chem.271: 30041 (1996)
M. Murakami, I. Kudo and K. Inoue. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian group II phospholipase A2. FEBS Lett.294: 247 (1991)
M. MacPhee, K.P. Chepenik, R. Liddell, K.K. Nelson, L.D. Siracusa, and A.M. Buchberg. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of Apc Mim-induced intestinal neoplasia. Cell 81:957(19
M. Murakami, H. Kuwata, H., Y. Amakasu, S. Shimbara, Y. Nakatani, G. Atsumi, and I. Kudo. Prostaglandin E2 amplifies cytosolic phospholipase A2 and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells: enhancement by secretory phospholipase A2. J. Biol. Chem.272: 19891 (1997)
M. Murakami, Y. Nakatani, G. Atsumi, K. Inoue, and I. Kudo. Regulatory functions of phospholipase A2. Crit. Rev. Immunol.17: 225 (1997)
G. Atsumi, M. Murakami, M. Tajima, S. Shimbara, N. Hara, and I. Kudo. The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim. Biophys. Acta1349: 43 (1997)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kuwata, H., Sawada, H., Murakami, M., Kudo, I. (1999). Role of Type IIA Secretory Phospholipase A2 in Arachidonic Acid Metabolism. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_28
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4793-8_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7171-7
Online ISBN: 978-1-4615-4793-8
eBook Packages: Springer Book Archive